FDA Expands Indications for Bempedoic Acid in CVD Prevention FDA Expands Indications for Bempedoic Acid in CVD Prevention
Bempedoic acid and bempedoic –ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Heart Attack | Statin Therapy | Vytorin | Zetia